Huntingdon, United Kingdom

Gary Stuart Tilbrook

USPTO Granted Patents = 18 


 

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 116(Granted Patents)


Location History:

  • Bluntisham, GB (2015)
  • Campridgeshire, GB (2016)
  • Huntington, GB (2018)
  • Huntingdon, GB (2014 - 2021)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovations of Gary Stuart Tilbrook

Introduction

Gary Stuart Tilbrook is a prominent inventor based in Huntingdon, GB, known for his significant contributions to pharmaceuticals and medicinal chemistry. With an impressive portfolio of 18 patents, Tilbrook has developed groundbreaking innovations that advance the field of sedative and anxiolytic therapies.

Latest Patents

Tilbrook’s latest patents demonstrate his dedication to improving patient care through innovative pharmaceutical solutions. One of his notable inventions is related to short-acting benzodiazepine salts and their polymorphic forms. This invention focuses on the besylate salts of a specific compound, detailing methods for preparing these salts and their medicinal applications, particularly for sedative, hypnotic, anxiolytic, muscle relaxant, and anticonvulsant purposes. Another significant patent is the dosing regimen for sedation with CNS 7056 (Remimazolam), which outlines a regimen combining this fast-acting benzodiazepine with an opioid, specifically fentanyl. The patent recommends administering CNS 7056 in doses ranging from 2 to 20 mg, with an optimal range between 5 and 8 mg for effective sedation.

Career Highlights

Gary Tilbrook is currently associated with Paion UK Limited, a company focused on developing innovative medicinal products. His work at Paion has allowed him to explore new therapeutic avenues and contribute to the understanding and preparation of crucial pharmaceutical agents.

Collaborations

Throughout his career, Tilbrook has collaborated with notable professionals such as Karin Wilhelm-Ogunbiyi and Keith Borkett. These partnerships have played a crucial role in the development and success of his patented inventions, showcasing the importance of teamwork in scientific innovation.

Conclusion

Gary Stuart Tilbrook continues to be a key figure in pharmaceutical innovations, contributing to advancements in sedative and anxiolytic medications. His patents reflect a commitment to improving treatment methodologies while collaborating with talented colleagues to enhance the field of medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…